The Birhanmumbai Municipal Corporation starts Free Coronavirus Testing in Mumbai, started 244 new testing centers
On Sunday, 908 new coronavirus cases were reported in Mumbai and 5369 in the whole of Maharashtra. Talking about the overall infected person count to 2,58,408. The total death toll reached 10,275 in the city, and 44,024 cases were recorded in the whole state—16,83,775 cases reported in the state so far. The active number of cases came down to 1,25,109.
On 2 November, BMC (Brihanmumbai Municipal Corporation) declared that due to a continuous increase in the number of Covid-19 cases, It had facilitated 244 new Covid-19 centers across 24 wards facilitating free Covid-19 test.
This decision has been made to make the testing process easy for the residents and motivate them to test more and more.
These centers started their operation on 2 November. With this move, the Covid-19 test center count will cross the count of 300 in the city. Some of these centers will have RT-FCR facilities, and others will conduct an antigen test. This facility will be available between 10 AM to 12 PM (Walk basis). Citizens can gather the Covid-19 centers’ details by calling on the toll-free number 1916 or through the website (The link is shared below- http://stopcoronavirus.mcgm.gov.in.)
Apart from these centers, citizens may visit different private labs or hospitals with testing facilities to get themselves tested. BMC officials said it is a part of the strategy to fight the coronavirus and motivate them to test more. There are 54 private medical laboratories available for Covid-19 testing facilities. Around Rs.1800 is charged for home service, and Rs.1400 is charged for going to the facility and getting tested.
Although the city’s recovery rate is 89% with the doubling rate of 171 days, the growth rate between 25 to 31 October was 0.41%.
Bharat Biotech is developing India’s aboriginal coronavirus vaccine, planning to launch the vaccine in the 2nd quarter of 2021 only if it gets approval from a regulatory authority.
AIIMS Delhi is about to submit a plan to the ethics committee on phase 3 Covaxin clinical trials in November. Bharat Biotech has received approval from DCGI (Drugs Controller General of India to conduct its vaccine).
It is expected that the trial of covaxin will be conducted in 10-12 states (25 sites in each state) and will provide two doses each for the vaccine.
Please stay connected with us for more latest and genuine news and share thoughts by writing us in the comment section. Stay Home Stay Connected.